Search

NEW METHOD FACILITATES DEVELOPMENT OF ANTIBODY-BASED DRUGS

In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers have developed...

DR. HENRY JI TO PARTICIPATE IN THE H.C. WAINWRIGHT VIRTUAL GLOBAL LIFE SCIENCES CONFERENCE 2021 INVESTOR CONFERENCE

SAN DIEGO, March 04, 2021 - Sorrento Therapeutics, Inc. , announced today that Dr. Henry Ji, Chairman and CEO, will participate in...

 
 
 

HISTOGEN TO REPORT FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE

SAN DIEGO, March 04, 2021 - Histogen Inc. , a clinical-stage therapeutics company focused on developing potential first-in-class restorative...

ASSOCIATE DIRECTOR, TECHNICAL OPERATIONS/CMC-BIOLOGICS - TRAVERE THERAPEUTICS - SAN DIEGO, CA

Excellent decision-making and collaboration skills with strong attention to detail. The Associate Director, Technical Operations is...

 
 
 

CIDARA THERAPEUTICS: RESEARCH ASSOCIATE, IN VIVO

Cidara Therapeutics: Position Summary Animal technician to conduct in vivo studies in mice at our local vivarium. Will also be required...

OLFACTORY NEUROEPITHELIUM CELLS FROM CANNABIS USERS DISPLAY ALTERATIONS TO THE CYTOSKELETON AND TO MARKERS OF ADHESION, PROLIFERATION AND APOPTOSIS

Abstract Cannabis is the third most commonly used psychoactive substance of abuse, yet it also receives considerable attention as a...

 
 
 
FDA calls out Brainstorm's ALS stem cell therapy, says data don't show benefit

FDA CALLS OUT BRAINSTORM'S ALS STEM CELL THERAPY, SAYS DATA DON'T SHOW BENEFIT

A Brainstorm Cell Therapeutics therapy for Lou Gehrig's disease failed a pivotal study, but the company points to better results in...

NAD supports claims being made by ‘medical probiotic' manufacturer

NAD SUPPORTS CLAIMS BEING MADE BY ‘MEDICAL PROBIOTIC' MANUFACTURER

Probiotics manufacturer Pendulum Therapeutics Inc. got some welcome news today when the National Advertising Division announced that...

 
 
 
Takeda to pay Ovid $196M for full rights to Phase 3-ready epilepsy drug

TAKEDA TO PAY OVID $196M FOR FULL RIGHTS TO PHASE 3-READY EPILEPSY DRUG

Takeda Pharmaceutical gains full rights to a small molecule that has shown promise treating seizures in several rare forms of epilepsy....

A COMPREHENSIVE REVIEW ON ONCOGENIC MIRNAS IN BREAST CANCER

Abstract A growing body of evidence demonstrates that the oncogenic miRNAs are critical components that are involved in breast cancer...

 
 
 

DIABETES INDUCES DYSREGULATION OF MICRORNAS ASSOCIATED WITH SURVIVAL, PROLIFERATION AND SELF-RENEWAL IN CARDIAC PROGENITOR CELLS

Abstract Aims/hypothesis Diabetes mellitus causes a progressive loss of functional efficacy in stem cells, including cardiac progenitor...

SORRENTO THERAPEUTICS AND SCILEX HOLDING, A MAJORITY OWNED SUBSIDIARY, HAVE ENTERED INTO AN EXCLUSIVE LICENSING TERM SHEET WITH AARDVARK THERAPEUTICS TO ACQUIRE ITS ARD-301 FOR THE TREATMENT OF CHRONIC PAIN, FIBROMYALGIA, AND CHRONIC LONG HAUL COVID

SAN DIEGO, Calif., March 01, 2021 - Sorrento Therapeutics and Scilex Holdings Company , a majority owned subsidiary of Sorrento, have...

 
 
 

GRAPHENE OXIDE-SILVER NANOPARTICLES SHOWN TO RAPIDLY NEUTRALIZE RNA VIRUSES

While the vaccines against severe acute respiratory syndrome coronavirus 2 are administered, and extensive research is conducted for...

STUDY REVEALS PRESENCE OF GLIAL PLASTICITY, OFFERS FUTURE THERAPEUTIC STRATEGY FOR EPILEPSY

Tohoku University scientists and their colleagues in Germany have revealed that a first-time exposure to only a brief period of brain...

 
 
 

BIOINFORMATICS ANALYSIS IDENTIFIES IL6ST AS A POTENTIAL TUMOR SUPPRESSOR GENE FOR TRIPLE-NEGATIVE BREAST CANCER

Abstract Improved insight into the molecular mechanisms of triple-negative breast cancer is required to predict prognosis and develop...

MACROPHAGE MIGRATION INHIBITORY FACTOR FACILITATES THE THERAPEUTIC EFFICACY OF MESENCHYMAL STEM CELLS DERIVED EXOSOMES IN ACUTE MYOCARDIAL INFARCTION THROUGH UPREGULATING MIR-133A-3P

Exosome transplantation is a promising cell-free therapeutic approach for the treatment of ischemic heart disease. The purpose of this...

 
 
 

SCIENTIST - CELL BASED ASSAYS, ANALYTICAL DEVELOPMENT - POSEIDA THERAPEUTICS INC - SAN DIEGO, CA

Demonstrated proficiency in experimental design, data analysis, control charts and capability assessments using Design of Experiments...

Miracle Poison Holds Gateway To Novel Therapeutics

MIRACLE POISON HOLDS GATEWAY TO NOVEL THERAPEUTICS

Botulinum toxin proteins can be engineered to find new yet different protein targets with high selectivity, a critical advance toward...

 
 
 

DIRECT BIOLOGICS LLC: SENIOR SCIENTIST, ASSAY DEVELOPMENT

Negotiable, dependent upon experience; relocation package negotiable: Direct Biologics LLC: Become a founding member of an R&D team...

Merck commits $1.85B to Pandion in bid to boost immunology pipeline

MERCK COMMITS $1.85B TO PANDION IN BID TO BOOST IMMUNOLOGY PIPELINE

Merck's top immunology drugs face biosimiliar competition. The $1.85 billion acquisition of Pandion Therapeutics gives the pharma giant...